Oesophageal cancer, Secondary cancers, Stomach cancer
Results
Phase 2
This trial looked at tremelimumab for advanced food pipe (oesophageal) and stomach (gastric) cancer. Tremelimumab is also called CP-675206, and used to be called ticilimumab.
Recruitment start: 1 August 2006
Recruitment end: 19 March 2007
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Robert Hawkins
Pfizer
The Christie NHS Foundation Trust
Last reviewed: 7 December 2010
CRUK internal database number: 815